Stay updated on EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.

Latest updates to the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedA new site revision tag v3.6.2 was added, replacing v3.6.0, indicating a minor platform update reflected in the page's revision history.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new note states that recruitment is no longer ongoing, and the revision history has been updated to v3.6.0 with v3.5.5 removed, reflecting an administrative update to the record's versioning.SummaryDifference0.2%

- Check24 days agoChange DetectedThe page shows a new revision label (v3.5.5) indicating an administrative update to the record history.SummaryDifference0.0%

- Check45 days agoChange DetectedThe history now shows a new revision entry (v3.5.4) replacing the previous one (v3.5.3), indicating an update to the record metadata.SummaryDifference0.0%

- Check53 days agoChange DetectedThe history now includes new sections for Contacts/Locations and Study Status (with dates 2026-04-22 and 2026-05-07), enhancing visibility into site contacts and the trial's current status. An older entry dated 2025-07-08 was removed.SummaryDifference0.2%

- Check67 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the clinical trial record history.SummaryDifference0.0%

Stay in the know with updates to EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.